Teradyne beats Q3 targets and Q4 guidance but stock falls
Investor's Business Daily reported that Teradyne topped Wall Street's targets for the third quarter and its guidance for Q4, yet the stock fell. The post gives no figures or explanation for the decline.
Why “Unverified”
- Reported by Investor's Business Daily alone, with no second source or primary confirmation yet
1 independent source group across 1 post · evidence score 52/100. How labels work
What the sources claim
-
Teradyne beat Wall Street's third-quarter targets and its fourth-quarter guidance.
“Teradyne topped Wall Street's targets for the third quarter and with its guidance for Q4”
Investor's Business Daily -
Teradyne stock fell despite the results.
“But Teradyne stock fell”
Investor's Business Daily
Sources
More in Stocks & Indices
Summary and claims extracted by AI with prompt analyze-story@5 on 2026-10-27 20:50 UTC. Labels are computed from the sources, not by the model.